These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 12647363)
41. A short carboxy-terminal domain of polycystin-1 reorganizes the microtubular network and the endoplasmic reticulum. Gao H; Sellin LK; Pütz M; Nickel C; Imgrund M; Gerke P; Nitschke R; Walz G; Kramer-Zucker AG Exp Cell Res; 2009 Apr; 315(7):1157-70. PubMed ID: 19331813 [TBL] [Abstract][Full Text] [Related]
42. Transport function of the naturally occurring pathogenic polycystin-2 mutant, R742X. Chen XZ; Segal Y; Basora N; Guo L; Peng JB; Babakhanlou H; Vassilev PM; Brown EM; Hediger MA; Zhou J Biochem Biophys Res Commun; 2001 Apr; 282(5):1251-6. PubMed ID: 11302751 [TBL] [Abstract][Full Text] [Related]
43. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494 [TBL] [Abstract][Full Text] [Related]
44. Cardiovascular characterization of Pkd2(+/LacZ) mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2). Stypmann J; Engelen MA; Orwat S; Bilbilis K; Rothenburger M; Eckardt L; Haverkamp W; Horst J; Dworniczak B; Pennekamp P Int J Cardiol; 2007 Aug; 120(2):158-66. PubMed ID: 17182135 [TBL] [Abstract][Full Text] [Related]
45. Mutations of the human polycystic kidney disease 2 (PKD2) gene. Deltas CC Hum Mutat; 2001; 18(1):13-24. PubMed ID: 11438989 [TBL] [Abstract][Full Text] [Related]
46. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604 [TBL] [Abstract][Full Text] [Related]
47. Altered Hippo signalling in polycystic kidney disease. Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034 [TBL] [Abstract][Full Text] [Related]
48. [Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis]. Pérez-Oller L; Torra R; Badenas C; San Millán JL; Darnell A Nefrologia; 2000; 20(2):130-8. PubMed ID: 10853193 [TBL] [Abstract][Full Text] [Related]